In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer
Clinical trial NCT03492164 · TERMINATED
Trial details
- NCT number
- NCT03492164
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-20
- Primary completion
- 2024-06-11
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.